Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2007-02-09 WILSON ROBERT N Director Conversion · Series A Convertible Preferred Stock −67,495 0
2007-02-09 Gollust Keith R Director Conversion +235,454 1,150,970
2007-02-09 Gollust Keith R Director Purchase +180,000 $10.00 $1.8M 1,330,970
2007-02-09 Gollust Keith R Director Conversion · Series A Convertible Preferred Stock −300,000 0
2007-02-09 Williams Martin D Sr. VP, Business Dev., CBO Purchase +200 $10.00 $2K 200
2007-02-09 Jacobson Eric W Sr. VP, Research and CMO Purchase +300 $10.00 $3K 25,300
2006-11-17 Kovner Bruce Director Grant or award +2,857 87,954
2006-11-17 WILSON ROBERT N Director Grant or award +2,857 193,084
2006-11-17 Gollust Keith R Director Grant or award +2,857 34,357

Page 82 of 82 · 1,629 trades